Proteome Sciences plc (LON:PRM – Get Free Report) rose 3.4% during trading on Friday . The company traded as high as GBX 5 ($0.06) and last traded at GBX 4.64 ($0.06). Approximately 485,157 shares changed hands during trading, an increase of 165% from the average daily volume of 183,230 shares. The stock had previously closed at GBX 4.49 ($0.06).
Proteome Sciences Price Performance
The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The business’s 50-day simple moving average is GBX 3.84 and its 200 day simple moving average is GBX 3.26. The firm has a market capitalization of £13.71 million, a P/E ratio of -3.36 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- What is a Stock Market Index and How Do You Use Them?
- Palantir Stock Skids—How Much Further Can It Fall?
- Investing In Preferred Stock vs. Common Stock
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
